Discovery of novel therapeutics for glioblastoma
Ended Cooperative Agreement Awarded Last action
- Award ID
- R43CA213695
- Recipient
-
Curtana Pharmaceuticals Inc. UEI PM1PJ3RUXZ54
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $300,000
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Originally
- Place of performance
- Austin, TX 78754, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $300,000 |
Quick answers
Who received award R43CA213695?
R43CA213695 was awarded to Curtana Pharmaceuticals Inc. by National Cancer Institute (National Institutes of Health) on September 13, 2017.
How much is award R43CA213695 worth?
$300,000 has been obligated on R43CA213695.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award